Navigation Links
Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Date:9/5/2007

CEOs, Venture Capitalists, Medical and Media Leaders Speakers and Panels;

Live Surgeries and 'Top 10' Innovations List to be Featured

CLEVELAND, Sept. 5 /PRNewswire/ -- Cleveland Clinic will host its annual Medical Innovation Summit, an international gathering of health care, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.

The 2007 Medical Innovation Summit will feature:

-- Nationally Recognized Speakers and Panelists: Sidney Taurel, Eli

Lilly; George Buckley, 3M; Bill Hawkins, Medtronic; Stephen Hemsley,

UnitedHealth Group; Tony Zook, AstraZeneca; and many other CEOs, top

venture investors, medical leaders and network correspondents will

explore top technology issues in cardiovascular medicine including

drug-eluting stents, stem cells, personalized care, wellness,

implantable devices, and treating arrhythmias of the heart. A complete

list of speakers is available online at

http://www.clevelandclinic.org/innovations/summit/.

-- "Top 10" Health Care Innovations: Cleveland Clinic clinicians and

researchers will announce and discuss their second annual selection of

the "Top 10" medical innovations they expect to have a significant

impact in 2008.

-- Live Surgeries: Two live, interactive surgeries will illustrate state

of the art treatments for cardiovascular disease. Surgeries will be

broadcast in the Bank of America Conference Center of the

InterContinental Hotel Cleveland each morning at 7:30 a.m.

This marks the fifth year Cleveland Clinic has hosted this international gathering of industry decision-makers to dissect advances revolutionizing health care and accelerate the application of life-saving cardiovascular technologies. The 2007 Medical Innovation Summit will draw 900 industry executives, entrepreneurs, venture capitalists and clinicians. Also featured will be the Cleveland Clinic's annual selection of the "Top 10" health care innovations, live, interactive surgeries and in-depth debates on industry challenges.

For more information on the Medical Innovation Summit, including the agenda, please visit http://www.clevelandclinic.org/innovations/summit/.

CCF Innovations, the commercialization and innovation arm of Cleveland Clinic, organizes the Medical Innovation Summit, promotes innovation and is responsible for commercialization of all Cleveland Clinic technologies. CCF Innovations advances product-oriented innovation and transforms promising therapies, devices and diagnostics into beneficial medical products, via spin- off companies, licensees and equity partnerships.

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. Approximately 1,800 full-time salaried physicians and researchers at Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical specialties and subspecialties. In 2006, there were 3.1 million outpatient visits to Cleveland Clinic. Patients came for treatment from every state and from more than 80 countries. There were more than 53,000 hospital admissions to Cleveland Clinic in 2006. Cleveland Clinic's Web site address is http://www.clevelandclinic.org.


'/>"/>
SOURCE Cleveland Clinic
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
2. High iron levels may cause Cardiovascular Disease in women
3. Air Pollution said To Increase Risk of Cardiovascular Disease
4. Link Between Alcohol Consumption And Cardiovascular Disease
5. Beer Found To Be Effective In Fighting Cardiovascular Disease
6. New Guidelines Found To Benefit Cardiovascular Treatment
7. Women With A High-Risk Of Cardiovascular Disease Under treated
8. People who fight wars may be at high risk of cardiovascular disease
9. Low glycemic diet effective for reducing cardiovascular risk
10. Air pollution to affect diabetes patients’ cardiovascular risks
11. Need for considering cardiovascular risks before giving HAART for HIV/aids patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... The Global Wellness Summit (GWS), an annual conference for international ... travel, spa and beauty in Europe. The organization asked its partner experts in Europe ... researchers - to forecast where wellness is headed in Europe. Predictions range from European ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... The Orthopaedic ... executive committee members: , David G. Lewallen, MD, began his term as president ... president. Michael L. Parks, MD, is OREF’s new president-elect. Richard F. Kyle, MD, will ...
(Date:5/31/2016)... , ... May 31, 2016 , ... In a recent ... Feiner and broadcast on New Rochelle, NY-based WVOX (1460 AM), leading medical ... what she calls the country’s “modern medical money maelstrom.” , During the interview ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet a growing demand ... industry, The University of Scranton is adding a Certificate in Health Informatics to ... in rapidly growing field of healthcare information. , Healthcare organizations are under ...
(Date:5/30/2016)... , ... May 30, 2016 , ... ... use inside of FCPX," said Christina Austin - CEO of Pixel Film Studios. ... use within Final Cut Pro X. Choose from abstract transitions to more simple ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 2016 RnRMarketResearch.com adds "Asthma - ... analysis of Asthma therapy at various stages, therapeutics assessment ... administration (RoA) and molecule type, along with latest updates, ... key players involved in the therapeutic development for Asthma ... Complete report on H1 2016 pipeline review of ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
Breaking Medicine Technology: